Avantor, Inc. (NYSE:AVTR) Shares Sold by Park Avenue Securities LLC

Park Avenue Securities LLC reduced its position in Avantor, Inc. (NYSE:AVTR) by 2.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 44,323 shares of the company’s stock after selling 974 shares during the quarter. Park Avenue Securities LLC’s holdings in Avantor were worth $1,147,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Boston Partners increased its position in Avantor by 2.2% in the 1st quarter. Boston Partners now owns 28,561,802 shares of the company’s stock valued at $729,298,000 after acquiring an additional 624,369 shares during the period. Canada Pension Plan Investment Board increased its holdings in shares of Avantor by 6.8% in the second quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock valued at $486,059,000 after purchasing an additional 1,463,695 shares during the period. Artemis Investment Management LLP raised its stake in shares of Avantor by 14.9% during the first quarter. Artemis Investment Management LLP now owns 9,120,083 shares of the company’s stock worth $233,109,000 after purchasing an additional 1,180,937 shares during the last quarter. 1832 Asset Management L.P. lifted its holdings in shares of Avantor by 1,634.9% during the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock worth $180,839,000 after purchasing an additional 8,038,451 shares during the period. Finally, Bessemer Group Inc. grew its position in Avantor by 4.4% in the 1st quarter. Bessemer Group Inc. now owns 7,099,848 shares of the company’s stock valued at $181,544,000 after buying an additional 297,534 shares during the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Trading Down 0.7 %

Shares of Avantor stock opened at $24.82 on Wednesday. Avantor, Inc. has a 1 year low of $16.63 and a 1 year high of $28.00. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. The business has a 50 day moving average price of $25.81 and a 200 day moving average price of $24.37. The company has a market capitalization of $16.86 billion, a P/E ratio of 63.59, a P/E/G ratio of 2.71 and a beta of 1.33.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. The business had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.70 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. Sell-side analysts anticipate that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.50% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on AVTR shares. Wells Fargo & Company started coverage on shares of Avantor in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $30.00 target price for the company. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $34.00 price objective on shares of Avantor in a report on Thursday, September 26th. Stifel Nicolaus increased their target price on Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. UBS Group reduced their price target on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday. Finally, Robert W. Baird upped their price objective on Avantor from $26.00 to $27.00 and gave the stock an “outperform” rating in a report on Monday, July 29th. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $28.00.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.